
Ocugen Secures Licensing Agreement for OCU400 in Korea
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed a binding term sheet with a prominent pharmaceutical and healthcare company in Korea, granting exclusive Korean rights to OCU400, its experimental …
Ocugen Secures Licensing Agreement for OCU400 in Korea Read More